Venture Capital

Alphi Capital: Inaugural Fund Closed At C$295 Million

By Amit Chowdhry ● Jan 13, 2025

Alphi Capital - a lower middle-market private equity firm focused on partnering with service-based companies in Canada - announced the final closing of its debut fund, Alphi Capital I, LP with total limited partner commitments of C$295 million. This fund had strong interest from investors and significantly exceeded its C$200 million target.

Recognize Announces Majority Investment in Sprout

By Amit Chowdhry ● Jan 13, 2025

Recognize - a private equity firm focused on investing in digital services businesses - announced that it has made a majority investment in IT asset disposition (ITAD) provider Sprout. And New Capital Partners, an investor in Sprout since 2019, will continue as a minority investor.

Palm Beach Capital: Strategic Investment In MBI Companies

By Amit Chowdhry ● Jan 13, 2025

Palm Beach Capital Fund VI - through one of its investment entities - announced that it has made a strategic investment in MBI Companies, a leading architecture and engineering design firm based in Knoxville, Tennessee.

Timberlyne: $180 Million (Series A) Raised To Develop Novel Therapies For Autoimmune Disorders

By Amit Chowdhry ● Jan 13, 2025

Timberlyne Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders, announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in-class monoclonal antibody targeting CD38, for diseases of high unmet medical needs. The funding was led by investors Abingworth, Bain Capital Life Sciences, and Venrock Healthcare Capital Partners, with participation from Boyu Capital, Lilly Asia Ventures, Braidwell LP, and 3H Health Investment.

Swift Ventures: Interview With General Partner Brett Wilson About The AI-Focused Firm Of Founders Backing Founders

By Amit Chowdhry ● Jan 13, 2025

Swift Ventures is a venture capital firm with roots in Berkeley, California that primarily invests in early-stage AI startups. Investments by Swift include Arize AI, Dash Bio, GrayMatter Robotics, Superhuman, SafelyYou, Tubi (acquired), and others. Started by the founders of TubeMogul – which was acquired by Adobe in 2016 – Swift touts “garage-to-IPO building and scaling expertise.” Pulse 2.0 interviewed Swift Ventures general partner Brett Wilson to learn more about the firm after its recent launch of a new AI Index.

nsave: $18 Million (Series A) Raised For Launching Investment Platform

By Amit Chowdhry ● Jan 13, 2025

nsave, a provider of compliant accounts abroad to people from countries with high inflation, announced launching an investment product, enabling people at risk of financial exclusion to protect and grow their wealth. The company also confirmed an $18 million Series A funding led by TQ Ventures with participation from Sequoia Capital, Y Combinator, ACE Ventures, and Proton Foundation to drive their growth.

RhyGaze: $86 Million (Series A) Raised To Develop Gene Therapies For Retinal Diseases

By Amit Chowdhry ● Jan 13, 2025

RhyGaze, a biotechnology company based in Basel, Switzerland, and Philadelphia, PA, announced that it has raised a Series A funding round of $86 million. The funding round was led by GV (Google Ventures), alongside Arch Venture Partners, F-Prime Capital, and founding investors BioGeneration Ventures and Novartis Venture Fund, who contributed $11 million to an earlier seed round.

Kardigan: $300 Million Raised For Modernizing Cardiovascular Drug Development

By Amit Chowdhry ● Jan 13, 2025

Kardigan - a heart health company modernizing cardiovascular drug development - announced it launched with a mission to develop multiple targeted treatments in parallel, bringing people with cardiovascular diseases closer to the cures they deserve. The company also recently closed a $300 million Series A financing led by Perceptive Advisors, ARCH Venture Partners, and Sequoia Heritage.

Andreessen Horowitz Partnering With Lilly On $500 Million Biotech Ecosystem Venture Fund

By Amit Chowdhry ● Jan 13, 2025

Andreessen Horowitz (a16z) Bio + Health announced a newly formed and first-of-its-kind venture capital fund to fuel broader innovation in human health in partnership with Eli Lilly and Company (Lilly). The Biotech Ecosystem Venture Fund aims to drive transformative progress in healthcare by investing in therapeutic platforms and technology companies that can bring new medicines and disease treatments to improve patients’ lives.

Saluda Medical: $100 Million Of Financing Closed

By Amit Chowdhry ● Jan 13, 2025

Saluda Medical - a commercial-stage medical device company focused on developing treatments for chronic neurological conditions utilizing a novel closed-loop and dose-control neuromodulation platform - announced the closing of a $100 million financing.

Normunity: $75 Million (Series B) Raised For Broadening Pipeline Of Novel Anti-Cancer Therapies

By Amit Chowdhry ● Jan 13, 2025

Normunity, a biotechnology company creating novel anti-cancer therapies, announced today that it closed a Series B funding round of $75 million. The funding was co-led by Samsara BioCapital and Enavate Sciences, alongside other new investors Regeneron Ventures, Pfizer Ventures and YK Bioventures, as well as existing investors Canaan Partners, Sanofi Ventures, Taiho Ventures, Osage Venture Partners, HongShan Capital Group, and Connecticut Innovations. And the Board of Directors will be expanded to include David Parry, PhD (Samsara), Sara Nayeem, MD (Enavate), and Marie-Clare Peakman, MD (Pfizer Ventures).

Tidal Cyber Buying Zero-Shot Security

By Amit Chowdhry ● Jan 13, 2025

Tidal Cyber, the Threat-Informed Defense company, announced the acquisition of Zero-Shot Security, the creator of an innovative artificial intelligence (AI) solution that simplifies and speeds the processing and analysis of threat intelligence.

R4 Capital: $10.6 Billion Surpassed In 2024

By Amit Chowdhry ● Jan 13, 2025

R4 Capital, a national affordable housing tax-credit syndicator, lender, and asset manager, and R4 Capital Funding (R4CF), R4's tax-exempt lending platform, announced in 2024 that it surpassed $10.6 billion in equity and mortgage financing since being founded. This was a significant year, marking the most equity closed in a single year, the largest mortgage loan volume closed in a single quarter, and the most important single asset equity investment in the company's history.

IQHQ: $900 Million Raised In 2024

By Amit Chowdhry ● Jan 13, 2025

IQHQ - a premier owner and developer of life science districts - announced that $900 million of new capital was raised in 2024, with the most recent closing occurring in December 2024.

Holly: AI-Based Government Hiring Platform Raises $2.2 Million

By Amit Chowdhry ● Jan 13, 2025

Holly, an AI-based platform modernizing government hiring, announced the closing of its $2.2 million oversubscribed pre-seed round, led by J2 Ventures with participation from Roble Ventures, Gaingels, and notable angel investors. And the funding will support Holly's platform as it works to solve the million-job government workforce vacancy crisis.

Ascend Capital Partners Acquires Majority Stake in Unison Therapy Services

By Amit Chowdhry ● Jan 13, 2025

Ascend Capital Partners - a healthcare-focused private equity firm dedicated to improving the access, affordability, and quality of healthcare for vulnerable and underserved populations - announced that it has acquired a majority stake in Unison Therapy Services, one of the largest outsourced therapy providers for Pre-K – 12 students in school- and community-based settings.

Tune Therapeutics: Over $175 Million (Series B) Raised For Advancing Field-Leading Epigenome Editing Programs

By Amit Chowdhry ● Jan 13, 2025

Leading epigenome editing company Tune Therapeutics announced the completion of over $175 million in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures, and Hevolution Foundation.

A2 Biotherapeutics: $80 Million (Series C) Raised For Advancing Clinical Development Of Precision Cell Therapies

By Amit Chowdhry ● Jan 12, 2025

A2 Biotherapeutics - a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to target tumor cells and protect normal cells selectively - announced the closing of its $80 million Series C financing round, supported by a syndicate of investors that includes The Column Group and Samsara BioCapital.

Valspring Capital: Fund I Closed Above Target At $255 Million

By Amit Chowdhry ● Jan 12, 2025

Valspring Capital, a healthcare-focused growth equity firm, announced the closing of its debut fund, Valspring Capital Fund I, above its target at $255 million. Launched in 2022 by a team spun off from Bain Capital Ventures to pursue healthcare investments with the firm’s support, the Valspring team will seek to invest primarily in growth-stage companies in the healthcare industry, focusing on the information technology, technology-enabled services, and services sectors within North America.

Phase Four: In-Space Propulsion Company Raises Series C

By Amit Chowdhry ● Jan 12, 2025

Phase Four, a leader in advanced in-space propulsion design and manufacturing, announced the first close of its Series C funding round, securing nearly 60% of the target raise with strong participation from new and existing investors. And the round is led by Artemis Group Capital, the Oklahoma-based investment firm helmed by former NASA Administrator Jim Bridenstine, emphasizing the growing confidence in Phase Four's innovative propulsion solutions.

RLTYco: $20 Million (Series A) Raised For Giving Agents Same-Day Commission Advances And Other Benefits

By Amit Chowdhry ● Jan 12, 2025

RLTYco, a New York-based full-service provider of comprehensive resources for real estate professionals, announced the closing of a $20 million Series A funding round led by Altriarch. The funding round also included participation from existing investors, including Andrew Dodge, entrepreneur and angel investor, Christopher Schmidt, Executive Vice President at Related Companies, and SERHANT. Ventures (SERHANT.’s education division that develops, creates, and produces resources and solutions for agents in today’s new marketplace). Ryan Serhant, CEO and founder of SERHANT., is a partner, advisor and ambassador via SERHANT. Ventures.

VertexOne: $131 Million Financing Commitment Raised From Runway Growth Capital And BC Partners Credit

By Amit Chowdhry ● Jan 12, 2025

Runway Growth and BC Partners Credit, announced a $131 million financing commitment to VertexOne. BC Partners Credit is the $8 billion credit arm of BC Partners, which is an alternative investment firm with about $40 billion AUM.

Origis Energy: $415 Million Funding Package Closed

By Amit Chowdhry ● Jan 12, 2025

Origis Energy, one of America's leading renewable energy and decarbonization solution platforms, announced the closing of financing for the Swift Air Solar project in Ector County, Texas. The $415 million funding package includes construction, term debt, and tax equity financing from Natixis Corporate & Investment Banking (CIB) and Advantage Capital.

Grand Games: $30 Million (Series A) Raised To Accelerate Growth

By Amit Chowdhry ● Jan 12, 2025

Grand Games, a gaming studio behind the widely loved Magic Sort mobile game, announced it has raised a $30 million Series A round, marking its arrival as the latest up-and-coming studio to emerge from Istanbul, the gaming powerhouse that brought forth Dream Games and Peak Games. Balderton Capital led the round with participation from existing investors Bek Ventures (formerly known as Earlybird Digital East), Laton Ventures, and angel investor Mert Gür.

Prudentia Sciences: AI-Based Life Sciences Marketplace Company Raises $7 Million

By Amit Chowdhry ● Jan 12, 2025

Prudentia Sciences, an AI-based technology platform for life sciences announced its public launch, supported by $7 million in funding. This funding round was led by GV, with participation from Iaso Ventures and Virtue.

Tenvie Therapeutics Raises $200 Million For Delivering Small Molecule Therapies

By Amit Chowdhry ● Jan 12, 2025

Advanced Ionics: Green Hydrogen Electrolyzer Company Raises $6.7 Million

By Amit Chowdhry ● Jan 12, 2025

Advanced Ionics, a developer of a new class of green hydrogen electrolyzers aimed at accelerating decarbonization, announced that it raised an additional $6.7 million in funding from strategic investors JERA, Lummus Venture Capital, the Argosy Foundation, and existing investors Clean Energy Venture Group and bp Ventures.

Bonaccord Capital Partners: Fund II Closes At $1.6 Billion

By Amit Chowdhry ● Jan 12, 2025

Bonaccord Capital Partners - a private equity business focused on providing growth capital and strategic support to middle-market private markets sponsors - announced the final close of its second GP Stakes fund, Bonaccord Capital Partners II (BCP II), with $1.6 billion in total commitments.

Absci Raising $20 Million From AMD

By Amit Chowdhry ● Jan 12, 2025

Absci Corporation, a data-first generative AI-based drug creation company, announced a strategic collaboration with AMD to deploy AMD Instinct accelerators and ROCm software to power critical AI drug discovery workloads, including Absci's advanced de novo antibody design models. And AMD will also make a $20 million investment in Absci, structured as a private investment in public equity (PIPE), highlighting the growing demand for innovative AI applications in drug discovery.

Vensana Capital: $425 Million Fund III Closed For Investing In Breakthrough Medical Technologies

By Amit Chowdhry ● Jan 12, 2025

Vensana Capital announced the closing of Vensana Capital III with $425 million in committed capital. This fund was oversubscribed at its hard cap with the support of the firm’s existing limited partners alongside select new institutional investors, and it brings Vensana’s total capital under management to about $1 billion.